6-31715510-A-T

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_021246.4(LY6G6D):​c.64A>T​(p.Met22Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000558 in 1,612,568 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.000046 ( 0 hom., cov: 31)
Exomes 𝑓: 0.0000014 ( 0 hom. )

Consequence

LY6G6D
NM_021246.4 missense

Scores

17

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 0.288
Variant links:
Genes affected
LY6G6D (HGNC:13935): (lymphocyte antigen 6 family member G6D) LY6G6D belongs to a cluster of leukocyte antigen-6 (LY6) genes located in the major histocompatibility complex (MHC) class III region on chromosome 6. Members of the LY6 superfamily typically contain 70 to 80 amino acids, including 8 to 10 cysteines. Most LY6 proteins are attached to the cell surface by a glycosylphosphatidylinositol (GPI) anchor that is directly involved in signal transduction (Mallya et al., 2002 [PubMed 12079290]).[supplied by OMIM, Apr 2009]
LY6G6F-LY6G6D (HGNC:38821): (LY6G6F-LY6G6D readthrough) This locus represents naturally occurring readthrough transcription between the neighboring LY6G6F (lymphocyte antigen 6 family member G6F) and LY6G6D (lymphocyte antigen 6 family member G6D) genes on chromosome 6. The readthrough transcript encodes a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Jul 2017]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.072779745).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
LY6G6DNM_021246.4 linkuse as main transcriptc.64A>T p.Met22Leu missense_variant 2/3 ENST00000375825.8 NP_067069.2
LY6G6F-LY6G6DNM_001353334.2 linkuse as main transcriptc.811A>T p.Met271Leu missense_variant 5/6 NP_001340263.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
LY6G6DENST00000375825.8 linkuse as main transcriptc.64A>T p.Met22Leu missense_variant 2/31 NM_021246.4 ENSP00000364985.3 O95868
LY6G6F-LY6G6DENST00000503322.1 linkuse as main transcriptc.811A>T p.Met271Leu missense_variant 5/61 ENSP00000421232.1
LY6G6DENST00000375824.1 linkuse as main transcriptc.64A>T p.Met22Leu missense_variant 2/31 ENSP00000364984.1 F6XWZ1
LY6G6DENST00000479334.1 linkuse as main transcriptn.155A>T non_coding_transcript_exon_variant 1/21

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152086
Hom.:
0
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.000169
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.00000406
AC:
1
AN:
246490
Hom.:
0
AF XY:
0.00
AC XY:
0
AN XY:
134330
show subpopulations
Gnomad AFR exome
AF:
0.0000662
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1460482
Hom.:
0
Cov.:
34
AF XY:
0.00000138
AC XY:
1
AN XY:
726510
show subpopulations
Gnomad4 AFR exome
AF:
0.0000299
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.0000166
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152086
Hom.:
0
Cov.:
31
AF XY:
0.0000404
AC XY:
3
AN XY:
74278
show subpopulations
Gnomad4 AFR
AF:
0.000169
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.00
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000712
Hom.:
0
Bravo
AF:
0.0000340
ExAC
AF:
0.00000847
AC:
1

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsMay 01, 2024The c.64A>T (p.M22L) alteration is located in exon 2 (coding exon 2) of the LY6G6D gene. This alteration results from a A to T substitution at nucleotide position 64, causing the methionine (M) at amino acid position 22 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.18
BayesDel_addAF
Benign
-0.23
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
10
DANN
Benign
0.86
DEOGEN2
Benign
0.065
.;T;.
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.45
FATHMM_MKL
Benign
0.057
N
M_CAP
Benign
0.012
T
MetaRNN
Benign
0.073
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Benign
0.90
.;L;.
PROVEAN
Benign
-1.1
N;N;N
REVEL
Benign
0.075
Sift
Benign
0.28
T;T;T
Sift4G
Benign
0.089
T;T;T
Polyphen
0.24
.;B;.
Vest4
0.25
MutPred
0.27
.;Loss of catalytic residue at M22 (P = 8e-04);Loss of catalytic residue at M22 (P = 8e-04);
MVP
0.14
MPC
0.13
ClinPred
0.060
T
GERP RS
4.0
Varity_R
0.26
gMVP
0.29

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.010
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs759293818; hg19: chr6-31683287; API